Labcorp to Speak at the 44th Annual J.P. Morgan Healthcare Conference
Rhea-AI Summary
Labcorp (NYSE: LH) will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, 2026 at 4:30 p.m. PT. A live audio webcast will be available on the company investor relations site ir.Labcorp.com and will be archived for replay.
The presentation offers investors and analysts direct access to management commentary on strategy and market outlook; no financial results or guidance are included in this announcement.
Positive
- None.
Negative
- None.
News Market Reaction – LH
On the day this news was published, LH declined 0.87%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers show mixed, mostly modest moves: DGX -0.11%, NTRA -0.58%, MTD +0.01%, WAT -0.5%, IQV +0.72%, indicating the JP Morgan conference news is more company-specific than sector-driven.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 02 | Asset acquisition | Positive | -0.1% | Completed $194M cash acquisition of CHS outreach lab assets across 13 states. |
| Nov 24 | Board appointment | Positive | -0.1% | Appointed Novartis U.S. leader Victor Bulto to Labcorp’s Board of Directors. |
| Nov 19 | Clinical data | Positive | +0.3% | Published MRD Plasma Detect studies in Nature Medicine and Clinical Cancer Research. |
| Oct 28 | Earnings results | Positive | -5.8% | Reported Q3 2025 revenue and EPS growth with updated full-year guidance and cash flow. |
| Oct 23 | Product launch | Positive | +0.4% | Announced nationwide offering of Roche’s FDA-cleared Elecsys pTau181 Alzheimer’s test. |
Recent positive strategic and clinical announcements have often seen muted or even negative next-day price reactions, especially around earnings and M&A.
Over the last few months, Labcorp announced a $194 million outreach lab asset acquisition on Dec 2, 2025, added an experienced pharma leader to its board effective Dec 1, 2025, and highlighted MRD assay data in major journals. Q3 2025 results showed revenue of $3.56B and strong EPS growth but drew a -5.79% reaction. The Alzheimer’s blood test launch news in late October saw a small positive move, underscoring that fundamental milestones have produced modest, inconsistent price responses.
Market Pulse Summary
This announcement highlights Labcorp’s participation in the high-profile J.P. Morgan Healthcare Conference on Jan. 13, giving management a platform to discuss strategy, capital allocation, and recent initiatives such as acquisitions and new diagnostics offerings. Historically, solid earnings and clinical data have not always translated into strong price moves. Investors may focus on any updated commentary on revenue growth, EPS trajectory, and integration of recent transactions during the fireside chat.
AI-generated analysis. Not financial advice.
BURLINGTON, N.C., Dec. 30, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that the company will participate in a fireside chat at the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 13, at 4:30 p.m. PT.
A live audio webcast of the fireside chat will be available via the Company Investor Relations website at ir.Labcorp.com and archived for replay.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than
View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-to-speak-at-the-44th-annual-jp-morgan-healthcare-conference-302650873.html
SOURCE Labcorp Holdings Inc
FAQ
When will Labcorp (LH) present at the 44th J.P. Morgan Healthcare Conference?
How can investors listen to Labcorp's (LH) fireside chat on Jan. 13, 2026?
Will Labcorp (LH) provide a replay of the J.P. Morgan conference presentation?
What topics will Labcorp (LH) cover at the J.P. Morgan Healthcare Conference fireside chat?
Is the Labcorp (LH) fireside chat open to the public or only to conference attendees?
